The crispr technology market size has grown exponentially in recent years. It will grow from $2.53 billion in 2025 to $3.11 billion in 2026 at a compound annual growth rate (CAGR) of 23%. The growth in the historic period can be attributed to breakthrough discovery of crispr cas systems, limitations of conventional gene editing tools, rapid academic research adoption, declining sequencing costs, strong public research funding.
The crispr technology market size is expected to see exponential growth in the next few years. It will grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to clinical translation of gene editing therapies, growth of precision medicine, expansion of gene-edited crops, advancements in delivery technologies, strengthening regulatory frameworks. Major trends in the forecast period include expansion of therapeutic gene editing applications, growing adoption in agricultural biotechnology, increased use in functional genomics research, rising demand for advanced delivery systems, focus on precision and off-target reduction.
The growing number of ongoing clinical trials is expected to drive the expansion of the CRISPR technology market in the coming years. A clinical trial is a research study conducted in people to evaluate the safety and effectiveness of new medical treatments, devices, or therapeutic approaches. CRISPR technology is increasingly used in clinical trials for the treatment of a wide range of conditions, including cancer, blood disorders, inherited eye diseases, and infectious diseases. For example, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, the number of pharmaceutical industry trials initiated in the United Kingdom increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the rising number of ongoing clinical trials is contributing to the growth of the CRISPR technology market.
Major companies operating in the CRISPR technology market are concentrating on the development of advanced gene-editing tools to improve the accuracy of genomic modifications across applications in medicine, agriculture, and biotechnology. Gene-editing tools are technologies that enable precise changes to an organism’s DNA, allowing genetic material to be added, removed, or modified. Tools such as CRISPR-Cas9 support targeted gene alterations and continue to advance research in genetics, medicine, and biotechnology. For instance, in May 2024, Profluent Bio Inc., an Ireland-based AI-driven protein design company, launched OpenCRISPR-1 for editing the human genome. This platform delivers notable advantages by achieving a 95 percent reduction in off-target effects, thereby improving the precision of genetic modifications compared with conventional CRISPR systems. Its open-source framework also enables researchers worldwide to customize and optimize the tool for diverse applications, supporting ethical use and accelerating the development of novel therapies for genetic disorders.
In February 2023, Sherlock Biosciences, a US-based healthcare company that develops diagnostic tools to improve access to accurate and affordable health information, acquired Sense Biodetection for an undisclosed amount. Through this acquisition, Sherlock Biosciences aims to speed up the development of user-friendly, CRISPR-based diagnostic solutions that make reliable health testing more accessible to consumers. Sense Biodetection Limited is a UK-based molecular diagnostics company specializing in rapid, point-of-care diagnostic technologies.
Major companies operating in the crispr technology market are Crispr Therapeutics, Thermo Fisher Scientific, Intellia Therapeutics, Horizon Discovery, Synthego Corporation, Integrated Dna Technology (Danaher), Editas Medicine, GenScript, Agilent Technologies, New England Biolabs, CSIR-Institute of Genomics & Integrative Biology (IGIB), Strand Life Sciences Pvt. Ltd., Bio Palette Co. Ltd., CSL Limited, C4U Co. Ltd., BGI Group, Churchi Genome Engineering and Therapeutic Research Center., Beam Therapeutics Inc., Eurofins Genomics India, Setsurotech Co. Ltd., Merck Japan, Institut Pasteur, CureVac, Cellectis, BiovelocITA S.r.l., Evotec A.G., SNIPR Biome, Oxford Genetics, ERS Genomics, Alia Therapeutics, Solvo, BioTalentum, Rosneft, BIOCAD, BioVendor, Research & Diagnostic Products, Contipro, Lonza Biotec, Sotio, Selvita, BioVentures Institute Ltd, Sigma-Aldrich, Poseida Therapeutics, NanoCellect Biomedical, Sherlock Biosciences, Repare Therapeutics, Inscripta Inc., Santa Cruz Biotechnology, Caribou Biosciences Inc., Egenesis Inc., Homology Medicines, System Biosciences, Takara Bio USA Inc., Inari Agriculture Inc., Precision BioSciences, Cell Microsystems Inc., GeneCopoeia Inc., Merck KGaA, Origene Technologies Inc., Pluristem Therapeutics Inc.
North America was the largest region in the CRISPR technology market in 2025. Western Europe was the second largest region in the global CRISPR technology market. The regions covered in the crispr technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the crispr technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the crispr technology market by increasing costs of imported enzymes, plasmids, vectors, reagents, and laboratory instruments. Biotechnology companies and research institutions in North America and Europe are most affected due to reliance on imported research inputs, while Asia-Pacific faces higher technology acquisition costs. These tariffs are increasing research and development expenses. However, they are also encouraging domestic reagent production, regional manufacturing capabilities, and localized biotech supply chains.
The crispr technology market research report is one of a series of new reports that provides crispr technology market statistics, including crispr technology industry global market size, regional shares, competitors with a crispr technology market share, detailed crispr technology market segments, market trends and opportunities, and any further data you may need to thrive in the crispr technology industry. This crispr technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
CRISPR technology is a transformative gene-editing tool that allows precise alterations to DNA within living organisms. It is widely used to modify genes for a range of applications, including the treatment of diseases, improvements in agriculture, and advancements in biological research.
The main product types in the CRISPR technology market include design tools, plasmids and vectors, Cas9 and guide RNA, and delivery system products. CRISPR-Cas9 is a landmark technology that enables geneticists and medical researchers to edit specific sections of the genome by deleting, inserting, or modifying DNA sequences. The technology is applied across various areas such as genome editing or genetic engineering, genetically modified organisms, agricultural biotechnology, and other applications, and is utilized by multiple sectors including industrial biotechnology, biological research, agricultural research, therapeutics, and drug discovery.
The CRISPR technology market includes revenue earned by CRISPR Screening Libraries, CRISPR Positive Controls, CRISPR Negative Controls, and Gene-specific Knockout Kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The crispr technology market size is expected to see exponential growth in the next few years. It will grow to $6.92 billion in 2030 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to clinical translation of gene editing therapies, growth of precision medicine, expansion of gene-edited crops, advancements in delivery technologies, strengthening regulatory frameworks. Major trends in the forecast period include expansion of therapeutic gene editing applications, growing adoption in agricultural biotechnology, increased use in functional genomics research, rising demand for advanced delivery systems, focus on precision and off-target reduction.
The growing number of ongoing clinical trials is expected to drive the expansion of the CRISPR technology market in the coming years. A clinical trial is a research study conducted in people to evaluate the safety and effectiveness of new medical treatments, devices, or therapeutic approaches. CRISPR technology is increasingly used in clinical trials for the treatment of a wide range of conditions, including cancer, blood disorders, inherited eye diseases, and infectious diseases. For example, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, the number of pharmaceutical industry trials initiated in the United Kingdom increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Therefore, the rising number of ongoing clinical trials is contributing to the growth of the CRISPR technology market.
Major companies operating in the CRISPR technology market are concentrating on the development of advanced gene-editing tools to improve the accuracy of genomic modifications across applications in medicine, agriculture, and biotechnology. Gene-editing tools are technologies that enable precise changes to an organism’s DNA, allowing genetic material to be added, removed, or modified. Tools such as CRISPR-Cas9 support targeted gene alterations and continue to advance research in genetics, medicine, and biotechnology. For instance, in May 2024, Profluent Bio Inc., an Ireland-based AI-driven protein design company, launched OpenCRISPR-1 for editing the human genome. This platform delivers notable advantages by achieving a 95 percent reduction in off-target effects, thereby improving the precision of genetic modifications compared with conventional CRISPR systems. Its open-source framework also enables researchers worldwide to customize and optimize the tool for diverse applications, supporting ethical use and accelerating the development of novel therapies for genetic disorders.
In February 2023, Sherlock Biosciences, a US-based healthcare company that develops diagnostic tools to improve access to accurate and affordable health information, acquired Sense Biodetection for an undisclosed amount. Through this acquisition, Sherlock Biosciences aims to speed up the development of user-friendly, CRISPR-based diagnostic solutions that make reliable health testing more accessible to consumers. Sense Biodetection Limited is a UK-based molecular diagnostics company specializing in rapid, point-of-care diagnostic technologies.
Major companies operating in the crispr technology market are Crispr Therapeutics, Thermo Fisher Scientific, Intellia Therapeutics, Horizon Discovery, Synthego Corporation, Integrated Dna Technology (Danaher), Editas Medicine, GenScript, Agilent Technologies, New England Biolabs, CSIR-Institute of Genomics & Integrative Biology (IGIB), Strand Life Sciences Pvt. Ltd., Bio Palette Co. Ltd., CSL Limited, C4U Co. Ltd., BGI Group, Churchi Genome Engineering and Therapeutic Research Center., Beam Therapeutics Inc., Eurofins Genomics India, Setsurotech Co. Ltd., Merck Japan, Institut Pasteur, CureVac, Cellectis, BiovelocITA S.r.l., Evotec A.G., SNIPR Biome, Oxford Genetics, ERS Genomics, Alia Therapeutics, Solvo, BioTalentum, Rosneft, BIOCAD, BioVendor, Research & Diagnostic Products, Contipro, Lonza Biotec, Sotio, Selvita, BioVentures Institute Ltd, Sigma-Aldrich, Poseida Therapeutics, NanoCellect Biomedical, Sherlock Biosciences, Repare Therapeutics, Inscripta Inc., Santa Cruz Biotechnology, Caribou Biosciences Inc., Egenesis Inc., Homology Medicines, System Biosciences, Takara Bio USA Inc., Inari Agriculture Inc., Precision BioSciences, Cell Microsystems Inc., GeneCopoeia Inc., Merck KGaA, Origene Technologies Inc., Pluristem Therapeutics Inc.
North America was the largest region in the CRISPR technology market in 2025. Western Europe was the second largest region in the global CRISPR technology market. The regions covered in the crispr technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the crispr technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the crispr technology market by increasing costs of imported enzymes, plasmids, vectors, reagents, and laboratory instruments. Biotechnology companies and research institutions in North America and Europe are most affected due to reliance on imported research inputs, while Asia-Pacific faces higher technology acquisition costs. These tariffs are increasing research and development expenses. However, they are also encouraging domestic reagent production, regional manufacturing capabilities, and localized biotech supply chains.
The crispr technology market research report is one of a series of new reports that provides crispr technology market statistics, including crispr technology industry global market size, regional shares, competitors with a crispr technology market share, detailed crispr technology market segments, market trends and opportunities, and any further data you may need to thrive in the crispr technology industry. This crispr technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
CRISPR technology is a transformative gene-editing tool that allows precise alterations to DNA within living organisms. It is widely used to modify genes for a range of applications, including the treatment of diseases, improvements in agriculture, and advancements in biological research.
The main product types in the CRISPR technology market include design tools, plasmids and vectors, Cas9 and guide RNA, and delivery system products. CRISPR-Cas9 is a landmark technology that enables geneticists and medical researchers to edit specific sections of the genome by deleting, inserting, or modifying DNA sequences. The technology is applied across various areas such as genome editing or genetic engineering, genetically modified organisms, agricultural biotechnology, and other applications, and is utilized by multiple sectors including industrial biotechnology, biological research, agricultural research, therapeutics, and drug discovery.
The CRISPR technology market includes revenue earned by CRISPR Screening Libraries, CRISPR Positive Controls, CRISPR Negative Controls, and Gene-specific Knockout Kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. CRISPR Technology Market Characteristics
3. CRISPR Technology Market Supply Chain Analysis
4. Global CRISPR Technology Market Trends and Strategies
5. CRISPR Technology Market Analysis of End Use Industries
7. Global CRISPR Technology Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global CRISPR Technology Total Addressable Market (TAM) Analysis for the Market
9. CRISPR Technology Market Segmentation
10. CRISPR Technology Market Regional and Country Analysis
11. Asia-Pacific CRISPR Technology Market
12. China CRISPR Technology Market
13. India CRISPR Technology Market
14. Japan CRISPR Technology Market
15. Australia CRISPR Technology Market
16. Indonesia CRISPR Technology Market
17. South Korea CRISPR Technology Market
18. Taiwan CRISPR Technology Market
19. South East Asia CRISPR Technology Market
20. Western Europe CRISPR Technology Market
21. UK CRISPR Technology Market
22. Germany CRISPR Technology Market
23. France CRISPR Technology Market
24. Italy CRISPR Technology Market
25. Spain CRISPR Technology Market
26. Eastern Europe CRISPR Technology Market
27. Russia CRISPR Technology Market
28. North America CRISPR Technology Market
29. USA CRISPR Technology Market
30. Canada CRISPR Technology Market
31. South America CRISPR Technology Market
32. Brazil CRISPR Technology Market
33. Middle East CRISPR Technology Market
34. Africa CRISPR Technology Market
36. CRISPR Technology Market Competitive Landscape and Company Profiles
37. CRISPR Technology Market Other Major and Innovative Companies
40. CRISPR Technology Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
CRISPR Technology Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses crispr technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for crispr technology? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The crispr technology market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Design Tool; Plasmid And Vector; Cas9 And G-RNA; Delivery System Products2) By Application: Biomedical; Agriculture; Diagnostics; Other Applications
3) By End-User: Academic Research Organizations; Biopharmaceutical Companies; Agricultural Biotechnology Companies; Contract Research Organizations (CROs)
Subsegments:
1) By Design Tools: CRISPR Design Software; sgRNA Design Tools; Bioinformatics Platforms2) By Plasmid And Vector: Plasmid Vectors; Viral Vectors; Bacterial Vectors
3) By Cas9 And gRNA: Cas9 Proteins; Guide RNA (gRNA) Products; Cas9 Complexes
4) By Delivery System Products: Electroporation Systems; Lipid-Based Delivery Systems; Viral Delivery Systems; Nanoparticle-Based Delivery Systems
Companies Mentioned: Crispr Therapeutics; Thermo Fisher Scientific; Intellia Therapeutics; Horizon Discovery; Synthego Corporation; Integrated Dna Technology (Danaher); Editas Medicine; GenScript; Agilent Technologies; New England Biolabs; CSIR-Institute of Genomics & Integrative Biology (IGIB); Strand Life Sciences Pvt. Ltd.; Bio Palette Co. Ltd.; CSL Limited; C4U Co. Ltd.; BGI Group; Churchi Genome Engineering and Therapeutic Research Center.; Beam Therapeutics Inc.; Eurofins Genomics India; Setsurotech Co. Ltd.; Merck Japan; Institut Pasteur; CureVac; Cellectis; BiovelocITA S.r.l.; Evotec A.G.; SNIPR Biome; Oxford Genetics; ERS Genomics; Alia Therapeutics; Solvo; BioTalentum; Rosneft; BIOCAD; BioVendor; Research & Diagnostic Products; Contipro; Lonza Biotec; Sotio; Selvita; BioVentures Institute Ltd; Sigma-Aldrich; Poseida Therapeutics; NanoCellect Biomedical; Sherlock Biosciences; Repare Therapeutics; Inscripta Inc.; Santa Cruz Biotechnology; Caribou Biosciences Inc.; Egenesis Inc.; Homology Medicines; System Biosciences; Takara Bio USA Inc.; Inari Agriculture Inc.; Precision BioSciences; Cell Microsystems Inc.; GeneCopoeia Inc.; Merck KGaA; Origene Technologies Inc.; Pluristem Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this CRISPR Technology market report include:- Crispr Therapeutics
- Thermo Fisher Scientific
- Intellia Therapeutics
- Horizon Discovery
- Synthego Corporation
- Integrated Dna Technology (Danaher)
- Editas Medicine
- GenScript
- Agilent Technologies
- New England Biolabs
- CSIR-Institute of Genomics & Integrative Biology (IGIB)
- Strand Life Sciences Pvt. Ltd.
- Bio Palette Co. Ltd.
- CSL Limited
- C4U Co. Ltd.
- BGI Group
- Churchi Genome Engineering and Therapeutic Research Center.
- Beam Therapeutics Inc.
- Eurofins Genomics India
- Setsurotech Co. Ltd.
- Merck Japan
- Institut Pasteur
- CureVac
- Cellectis
- BiovelocITA S.r.l.
- Evotec A.G.
- SNIPR Biome
- Oxford Genetics
- ERS Genomics
- Alia Therapeutics
- Solvo
- BioTalentum
- Rosneft
- BIOCAD
- BioVendor
- Research & Diagnostic Products
- Contipro
- Lonza Biotec
- Sotio
- Selvita
- BioVentures Institute Ltd
- Sigma-Aldrich
- Poseida Therapeutics
- NanoCellect Biomedical
- Sherlock Biosciences
- Repare Therapeutics
- Inscripta Inc.
- Santa Cruz Biotechnology
- Caribou Biosciences Inc.
- Egenesis Inc.
- Homology Medicines
- System Biosciences
- Takara Bio USA Inc.
- Inari Agriculture Inc.
- Precision BioSciences
- Cell Microsystems Inc.
- GeneCopoeia Inc.
- Merck KGaA
- Origene Technologies Inc.
- Pluristem Therapeutics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.11 Billion |
| Forecasted Market Value ( USD | $ 6.92 Billion |
| Compound Annual Growth Rate | 22.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 61 |
